The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
 
Enrique M. Ocio
No Relationships to Disclose
 
María-Victoria Mateos
No Relationships to Disclose
 
Felipe Prosper
No Relationships to Disclose
 
Jesus Martin
No Relationships to Disclose
 
Albert Oriol Rocafiguera
No Relationships to Disclose
 
Isidro Jarque
Honoraria - Amgen; Celgene; Janssen
Consulting or Advisory Role - Amgen; Celgene; Janssen
Research Funding - Amgen; Celgene; Janssen
 
Rebeca Iglesias
No Relationships to Disclose
 
Cristina Motlloo
No Relationships to Disclose
 
Maria Sole
No Relationships to Disclose
 
Paula Rodriguez-Otero
No Relationships to Disclose
 
Sara Martinez
Employment - PharmaMar
 
Eva Fernandez-Garcia
Employment - PharmaMar
 
Jean-Marie Michot
No Relationships to Disclose
 
Arturo Soto-Matos
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Jose Rodriguez Diaz -Pavon
Employment - PharmaMar
 
Vincent Ribrag
Honoraria - Bristol-Myers Squibb; Eisai; Gilead Sciences; Infinity Pharmaceuticals; PharmaMar; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Gilead Sciences; Infinity Pharmaceuticals; PharmaMar; SERVIER
Research Funding - arGEN-X BVBA; Epizyme; SERVIER
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Jesus San Miguel
No Relationships to Disclose